1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections

1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections

BackgroundThe Ankura II Thoracic Stent Graft System (Lifetech, Shenzhen, China) is an evolution of the Ankura stent graft. This study reports one-year outcomes of the Ankura II Thoracic Stent Graft System for endovascular treatment of Stanford type B aortic dissections.MethodsThe Ankura II Thoracic...

Full description

Bibliographic Details
Main Authors: Chang Shu, Hao He, Weiguo Fu, Wei Guo, Ming Li, Erping Xi, Shuguang Guo, Xueming Chen, Zhanxiang Xiao, Shiqiang Yu, Jianhua Huang, Xiangchen Dai, Zhiwei Wang, Wei Li, Qingshan Zheng, Quanming Li, Lunchang Wang, Xin Li, Junwei Wang, Feng Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Ankura II
RCT
thoracic endovascular aortic repair
type B aortic dissection
stent – evolution
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.805585/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.805585/full

Similar Items